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Purpose: Deep vein thrombosis (DVT) is a preventable cause of morbidity and mortality in
patients who are hospitalized. An important part of the mechanism of DVT prophylaxis
with intermittent pneumatic compression (IPC) is reduced venous stasis with increased
velocity of venous return. The conventional methods of IPC use low pressure and slow infla-
tion of the air bladder on the leg to augment venous return. Recently, compression devices
have been designed that produce high pressure and rapid inflation of air cuffs on the plan-
tar plexus of the foot and the calf. The purpose of this study is to evaluate the venous veloc-
ity response to high-pressure, rapid-inflation compression devices versus standard, low-pres-
sure, slow-inflation compression devices in healthy volunteers and patients with severe post-
thrombotic venous disease.
Method: Twenty-two lower extremities from healthy volunteers and 11 lower extremities
from patients with class 4 to class 6 post-thrombotic chronic venous insufficiency were stud-
ied. With duplex ultrasound scanning (ATL-Ultramark 9, Advanced Tech Laboratory,
Bothell, Wash), acute DVT was excluded before subject evaluation. Venous velocities were
monitored after the application of each of five IPC devices, with all the patients in the supine
position. Three high-pressure, rapid-compression devices and two standard, low-pressure,
slow-inflation compression devices were applied in a random sequence. Maximal venous
velocities were obtained at the common femoral vein and the popliteal vein for all the devices
and were recorded as the mean peak velocity of three compression cycles and compared with
baseline velocities.
Results: The baseline venous velocities were higher in the femoral veins than in the popliteal
veins in both the volunteers and the post-thrombotic subjects. Standard and high-pressure,
rapid-inflation compression significantly increased the popliteal and femoral vein velocities
in healthy and post-thrombotic subjects. High-pressure, rapid-inflation compression pro-
duced significantly higher maximal venous velocities in the popliteal and femoral veins in
both healthy volunteers and patients who were post-thrombotic as compared with standard
compression. Compared with the healthy volunteers, the patients who were post-throm-
botic had a significantly attenuated velocity response at both the popliteal and the femoral
vein levels.
Conclusion: High-pressure, rapid-inflation pneumatic compression increases popliteal and
femoral vein velocity as compared with standard, low-pressure, slow-inflation pneumatic
compression. Patients with post-thrombotic venous disease have a compromised hemody-
namic response to all IPC devices. However, an increased velocity response to the high-pres-
sure, rapid-inflation compression device is preserved. High-pressure, rapid-inflation pneu-
matic compression may offer additional protection from thrombotic complications on the
basis of an improved hemodynamic response, both in healthy volunteers and in patients who
were post-thrombotic. (J Vasc Surg 1999;29:593-9.)
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Deep vein thrombosis (DVT) is a preventable
cause of morbidity and mortality in patients who are
hospitalized and remains a major problem in the
postoperative period. Venous stasis, endothelial
injury, and hypercoagulability are important con-
tributors to the development of deep venous throm-
bosis as proposed in 1856 by Virchow .1
Intermittent pneumatic compression (IPC) is a
safe and effective method used to prevent the devel-
opment of deep vein thrombosis2-4 and may affect
two of the three factors proposed by Virchow.1 The
mechanism of IPC is thought to be twofold: a fluid
mechanical effect of IPC expels venous blood from
the lower extremities, which increases the velocity of
venous return and reduces stasis. Venous stasis can be
described as decreased venous return affected by
valvular abnormalities, venous obstruction, or possi-
ble endothelial injury. It has been shown radi-
ographically and isotopically that venous stasis
occurs especially in the lower leg.5-7 IPC also pro-
duces a hematologic alteration, which reduces the
hypercoagulable state with the enhancement of fib-
rinolytic activity8-11 and tissue factor pathway
inhibitor.12 In recent years, IPC has witnessed an
increased popularity for DVT prophylaxis. A meta-
analysis of more than 70 published trials of DVT
prophylaxis in patients for surgery has shown that
the use of mechanical prophylaxis significantly
reduces the rates of DVT and fatal pulmonary
embolism.4
The conventional methods of IPC use low-pres-
sure, slow-inflation compression with sequential or
single chambers attached to the calf or calf and thigh
to augment venous return. Recently, compression
devices have been designed that produce rapid com-
pression of the plantar plexus of the foot and calf to
augment venous return.
Patients with post-thrombotic venous disease are
known to be at an increased risk for the develop-
ment of postoperative thromboembolic complica-
tions.2 It has been observed that patients with post-
thrombotic venous disease have an intrinsic alter-
ation of hemostatic balance and fail to show the
same level of fibrinolytic enhancement with com-
pression as do healthy volunteers.11 Chronic
obstruction and decreased compliance potentially
can alter the hemodynamic response to compres-
sion, which further contributes to the risk of recur-
rent DVT.
The purpose of this study was the evaluation of
whether there is a hemodynamic difference with
high-pressure, rapid-inflation compression devices as
compared with low-pressure, slow-inflation com-
pression devices in healthy volunteers and patients
with post-thrombotic disease.
METHODS
Thirty-three limbs of 22 subjects were studied
with five different IPC devices. The subjects were
categorized as healthy volunteers (n = 11, 22
extremities) or patients with class 4 to class 6 post-
thrombotic venous disease (n = 11, 11 extremi-
ties).13 These classes of venous disease included
patients with swollen, pigmented limbs (grade 4),
limbs with venous ulcer (grade 5), and limbs with
healed venous ulcers (grade 6). The average age was
42.5 years for the healthy volunteers and 48 years for
the patients who were post-thrombotic. The healthy
volunteers had no history or physical findings of
venous or arterial disease. Routine venous duplex
scan examinations with a 5-MHz probe (ATL-
Ultramark 9, Advanced Tech Laboratory, Bothell,
Wash) were performed to exclude the presence of
asymptomatic DVT or evidence of previously unde-
tected chronic venous disease. This technique has
been described previously, and a 99% sensitivity rate
for the detection of proximal DVT has been
achieved in our vascular laboratory.14
The patients who were post-thrombotic had a
history of objectively documented proximal DVT
that was treated with long-term anticoagulation
therapy. All of these patients had venous duplex scan
evidence of recanalization and thickening of the vein
walls.
This study protocol was reviewed and approved
by the institutional review board of Temple
University Health Sciences Center, and each subject
signed an informed consent. Standard compression
was evaluated with two calf-length IPC devices: a
calf-length sequential compression device (SCD,
Kendall Healthcare Products Company, Mansfield,
Mass) and a calf-length single-chamber compression
device (DVT 10 Flowtron, Huntleigh Healthcare,
Manalapan, NJ). High-pressure, rapid-inflation
pneumatic compression was evaluated with three
different devices: a foot pump (Plexipulse, NuTech,
San Antonio Tex), a foot and calf pump (Plexipulse,
NuTech), and the Art-Assist foot and calf pump
(ACI Medical Corporation, San Marcos, Calif). The
compression devices were applied in random
sequence according to a table of random numbers. A
comparision of the peak pressure, inflation times,
and compression cycles of the devices used is listed
in Table I.
The subjects were studied in the Clinical
Research Center of Temple University Hospital.
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Each subject was placed in the supine position for a
minimum of 5 minutes before the application of the
first compression device, and baseline venous veloc-
ities were recorded in centimeters per second. The
selected compression device was applied and func-
tioned for 5 minutes to achieve hemodynamic equi-
librium. Maximal venous velocities were obtained
from the common femoral vein cephalad to the
saphenofemoral junction and from the mid popliteal
vein for all the devices and recorded as the mean
peak velocity of three compression cycles. The angle
of insonation of the ultrasound scan beam with the
vein was 60 degrees. Between the compression
units, the subjects were placed transiently in a
reverse Trendelenburg position to ensure the com-
plete filling of the lower extremity veins. The sub-
jects were returned to the supine position, and the
next compression was begun after the venous veloc-
ities had returned to baseline.
In a preliminary evaluation, the extended effect of
external pneumatic compression on venous hemody-
namics was studied. The venous velocity response
was monitored in subjects with compression gar-
ments in place for a period of 2 hours to determine
the velocity profile over time with compression.
Maximal velocities generated with compression
reached equilibrium after 1 to 2 minutes and
remained relatively constant. Therefore, a 5-minute
compression time was chosen as representative of the
velocity response expected in patients with prolonged
compression. The reverse Trendelenburg position
was used to fill the venous system between each
device to ensure that there was no venous volume
bias at the outset of compression against compression
units used subsequent to the first.
Maximal velocities were calculated and recorded
for each study subject. The effect of compression in
healthy limbs and diseased limbs were analyzed sep-
arately. Comparisons between healthy subjects and
patients who were post-thrombotic were performed
with a two-sample t test and within patient or vol-
unteer groups with a paired t test. A similar analysis
was performed that compared standard compression
and rapid inflation devices. A pairwise comparison
was performed for all the compression devices used.
RESULTS
The baseline velocities were higher in the
femoral vein than in the popliteal vein in both the
volunteers and the post-thrombotic subjects. Each
compression unit increased the velocity in the
femoral and popliteal veins in each subject.
However, a greater relative velocity response
occurred in the popliteal veins.
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 4 Malone et al 595
Table I. Comparison of the mechanical properties of the compression devices
Tissue compression Peak pressure (mm Hg) Inflation time (s) Cycle (s)
Standard
CSQ Calf 50 11 60
CSC Calf 40 12 60
High pressure
FP Foot 160 2 22
FCP Foot and calf 160 2 22
AA Foot and calf 120 1 to 2 30
CSQ, Calf-length sequential compression device; CSC, calf-length, single-chamber compression device; FP, foot pump; FCP, foot and
calf pump; AA, Art-Assist foot and calf pump.
Table II. Mean increase in maximal venous velocity with compression
Popliteal Femoral
Increase with Increase with 
Baseline compression Baseline compression
(mm Hg) (mm Hg) P value (mm Hg) (mm Hg) P value
Healthy subjects
High pressure 11.4 ± 2.1 37.3 ± 4.1 <.05 13.7 ± 3.2 31.6 ± 4.8 <.05
Standard 11.4 ± 2.1 20.4 ± 5.1 <.05 13.7 ± 3.2 15.6 ± 6.7 <.05
P value <.05 <.05
Post-thrombotic patients
High pressure 9.8 ± 2.2 22.3 ± 3.8 <.05 11.4 ± 3.1 16.1 ± 5.3 <.05
Standard 9.8 ± 2.2 12.9 ± 2.1 <.05 11.4 ± 3.1 12.5 ± 4.3 <.05
P value <.05 <.05
High-pressure, rapid-inflation compression pro-
duced uniformly higher velocities than did standard
compression at both the popliteal and the femoral
vein levels. However, patients who were post-
thrombotic had a significantly attenuated velocity
response at both levels with all the compression
units (Table I).
The relative velocity augmentation with com-
pression is listed in Table II, which compares stan-
dard and high-pressure compression in healthy vol-
unteers and patients who were post-thrombotic.
These data show the relative increase in maximal
venous velocity with high-pressure, rapid-inflation
compression in all the subjects and the relatively
attenuated velocity response in patients who were
post-thrombotic. Although there is an attenuated
velocity response in patients who were post-throm-
botic to all the compression devices, relatively high-
er maximal velocities are observed with the high-
pressure, rapid-inflation compression devices (Tables
III and IV).
A pair-wise comparison of the maximal velocities
achieved with the five compression units showed a
significantly higher maximal venous velocity from
each high-pressure compression unit as compared
with each standard compression unit (Table V).
However, there were no differences in maximal
venous velocities between the high-pressure com-
pression units or between the low-pressure, slow-
inflation units.
DISCUSSION
The important findings of this study are that
there is a significantly higher maximal velocity
response to high-pressure, rapid-inflation intermit-
tent pneumatic compression and that individuals
with objectively confirmed post-thrombotic deep
venous disease have a compromised response to
IPC.
It is not yet known that high-pressure, rapid-
inflation compression translates to clinical superiori-
ty, namely decreased venous thrombosis. However, a
number of observations would lead one to hypothe-
size that this is true. It is intuitive that veins with
accelerated velocities are less likely to thrombose
than are veins with slower velocities. Clinical studies
have confirmed that high-pressure, rapid-inflation
compression is effective in reducing the occurrence
of DVT in surgical patients who are at a high risk.4
Although acceleration of a static volume of blood in
the venous system appears to be advantageous, it
may not be the only hemodynamic benefit. Similar
high-pressure compression units have been shown to
increase lower extremity arterial perfusion, which
increases blood flow through the popliteal artery
and increases foot skin perfusion.15 It follows that
increasing arterial inflow would provide an addition-
al volume of blood in the venous system. Therefore,
a larger volume of blood would be compressed with
the high-pressure, rapid-inflation compression units
and returned at higher maximal velocities.
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Table III. Maximal velocity increases with compression (healthy volunteers vs patients who were post-
thrombotic)
Compression (mm Hg)
Standard High-pressure, rapid-inflation
Popliteal
Healthys 20.4 ± 5.1 37.3 ± 4.1
Post-thrombitic 12.9 ± 2.1 22.3 ± 3.8
P value <.05 <.05
Femoral
Healthys 15.6 ± 6.7 31.6 ± 4.8
Post-thrombitic 12.5 ± 4.3 16.1 ± 5.3
P value <.05 <.05
Table IV. Relative velocity augmentation with compression
Popliteal Femoral
Standard High Standard High
Healthy volunteers 179% 327% 114% 230%
(145% to 215%) (268% to 417%) (75% to 155%) (185% to 249%)
Post-thrombotic patients 131% 228% 110% 141%
(94% to 155%) (175% to 241%) (66% to 128%) (110% to 180%)
The subjects in this study underwent evaluation
in the supine position to simulate the hemodynam-
ics expected with routine patient care, not the posi-
tion that would maximize the venous velocity
response to compression. Because the reverse
Trendelenburg position appears to improve the
hemodynamics of compression (maximal velocity
response), it may be prudent for patients to be
placed in the reverse Trendelenburg position to take
advantage of the maximal acceleration of venous
return16 and the augmentation of arterial inflow.15
Unfortunately, we have found that nursing person-
nel have difficulty maintaining patients in the reverse
Trendelenburg position for any extended period of
time.
High-pressure, rapid-inflation may offer an
incremental hematologic advantage. In a prior study,
high-pressure, rapid-inflation compression with a
foot compression device was found to increase
endogenous fibrinolytic activity11 and to increase tis-
sue factor pathway inhibitor, which correlated with
reduction of factor VIIa.12 Although there was no
difference between a high-pressure, rapid-inflation
compression foot device and a standard calf-length
or long-leg compression device, the observation was
compelling that high-pressure, rapid-inflation com-
pression of a small volume of tissue (foot) produced
a similar hematalogic response to standard long-leg
(calf and thigh) compression. Unfortunately, high-
pressure, rapid-inflation foot and calf compression
was not available for evaluation during the prior
study.
Although the mechanism for stimulating the
hematologic alteration is not known, it is reasonable
to postulate that increased shear stress on the vessel
wall is important. Shear stresses that act on the
endothelium arise from the radial velocity gradient
characteristic of blood flow through a vessel, with
slow flow (no flow) at the wall of the vessel and lay-
ers of increasing velocity that reach maximal veloci-
ty in center stream. There is increasing evidence that
the size of the blood vessels and the vascular tone are
dependent on the local level of shear stress and that
endothelial cells mediate the response of vessels to
changes in flow conditions.17-20 Most of the work in
this area has been performed with cultured endothe-
lial cells. However, there appears to be a consistency
of observations with cell culture studies and clinical
studies in humans. Although a higher maximal
venous velocity and more rapid acceleration (shear)
of venous return has strong theoretical and experi-
mental evidence that supports its benefit, there is no
direct clinical evaluation that supports a “patient
outcome” advantage. Some might suggest that the
lower but sustained velocity increase with low-pres-
sure, slow-inflation compression devices is more
beneficial than a transiently higher maximal velocity.
This seems to be an important question. The clincal
answer will necessitate a prospective trial with a large
sample size.
Increased shear stress on endothelial cells has
been found to increase the production of prostacy-
clin,21 endothelial-derived relaxing factor (nitric
oxide),22-24 platelet-derived growth factor,25 and tis-
sue-type plasminogen activator.26 On the other
hand, an increase in shear stress reduces the produc-
tion of interleukin-627 and alters pinocytosis28 and
transendothelial permeability.29 These cell culture
studies support the concept that physical measures
that increase velocity (shear) are beneficial and that
many and varied physiologic responses may be oper-
ative in addition to potentiation of fibrinolytic activ-
ity and alteration of the tissue factor pathway.
The patients in the study who were post-throm-
botic had objectively documented residual disease in
their deep veins, documented with recanalization or
thickened walls on duplex scan imaging. They had a
significantly compromised response to all the com-
pression units. However, high-pressure, rapid-infla-
tion compression generated higher maximal veloci-
ties than did standard compression. In a study that
evaluated the fibrinolytic effects of IPC, the patients
who were post-thrombotic were found to have
lower baseline endogenous fibrinolytic activity than
did the healthy subjects. It appears that there may be
a correlation of the hemodynamic response with the
hematologic response to IPC in similarly selected
patients, which would explain why these patients are
at a considerably higher risk of future venous throm-
boembolic events. Although high-pressure, rapid-
inflation compression shows improvement as com-
pared with standard compression, it may not be
enough to protect these patients at high risk from
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Table V. Intermittent pneumatic compression:
pair-wise comparison of five compression units
CSC CSQ FP FCP AA
CSC 1.0 0.56 <0.05 <0.05 <0.05
CSQ 0.56 1.0 <0.05 <0.05 <0.05
FP <0.05 <0.05 1.0 0.52 0.46
FCP <0.05 <0.05 0.52 1.0 0.53
AA <0.05 <0.05 0.46 0.53 1.0
CSC, Calf-length, single-chamber compression device; CSQ, calf-
length sequential compression device; FP, foot pump; FCP, foot
and calf pump; AA, Art-Assist foot and calf pump.
DVT. We would favor the combination of pharma-
cologic and mechanical prophylaxis to offer maximal
protection for patients with post-thrombotic venous
disease.
The capability to stimulate accelerated venous
return may be affected by the intrinsic properties of
the veins, most notably obstruction and diminished
compliance resulting from their thrombotic event.
The elasticity of the venous system changes with age
and post-thrombotic disease.30 Salvian and Baker31
evaluated the effects of pneumatic compression on
post-thrombotic limbs and found no difference
when compared with the healthy subjects. Their
selection of patients who were post-thrombotic dif-
fered from ours in that their patients had patent
venous systems with no evidence of obstruction.
Our patients had severe clinical disease and evidence
of obstruction shown by recanalization and thick-
ened vein walls.
Unfortunately, there is no good method to non-
invasively quantitate the degree of physiologic
obstruction in the post-thrombotic venous system.
We know that a large cross-sectional area of the vein
lumen can be obliterated yet preserve “normal”
maximal venous outflow at rest.32 It is apparent that
the degree of physiologic obstruction to venous
return in patients who were post-thrombotic is fre-
quently underestimated. Although venous duplex
scan findings of recanalization and thickened vein
walls are not physiologic nor quantitative, the find-
ings suggest that obstruction of the venous system
persists in the subjects studied and offers a potential
explanation for the different velocity response in
these patients who were post-thrombotic.
Ricci et al33 studied the hemodynamic effects of
high-pressure, rapid-inflation compression devices as
compared with standard IPC. Their observations
were similar to ours in terms of the augmentation of
peak velocity in the popliteal vein with the high-
pressure, rapid-inflation devices. It is not clear why
their observation of the femoral vein velocities were
inconsistent with ours. They found a longer sus-
tained venous flow pattern and a slower return to
baseline velocity with standard calf IPC. This would
be expected because the inflation time is longer as
compared with the high-pressure devices studied.
The observations that high-pressure, rapid-infla-
tion pneumatic compression shows higher maximal
venous velocities and that patients who are post-
thrombotic have a compromised response to com-
pression have important implications for clinical care
and future studies. When deciding on methods of
DVT prophylaxis, consideration should be given to
stratifying patients according to the status of their
deep venous system. Future studies in this area
should take these issues into consideration and
should include high-pressure, rapid-inflation com-
pression as part of the protocol.
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